245 related articles for article (PubMed ID: 24246598)
1. Methylxanthine use for apnea of prematurity among an international cohort of neonatologists.
Abu Jawdeh EG; O'Riordan M; Limrungsikul A; Bandyopadhyay A; Argus BM; Nakad PE; Supapannachart S; Yunis KA; Davis PG; Martin RJ
J Neonatal Perinatal Med; 2013; 6(3):251-6. PubMed ID: 24246598
[TBL] [Abstract][Full Text] [Related]
2. Caffeine for apnea of prematurity: a neonatal success story.
Kreutzer K; Bassler D
Neonatology; 2014; 105(4):332-6. PubMed ID: 24931325
[TBL] [Abstract][Full Text] [Related]
3. Methylxanthine therapy for apnea of prematurity: evaluation of treatment benefits and risks at age 5 years in the international Caffeine for Apnea of Prematurity (CAP) trial.
Schmidt B
Biol Neonate; 2005; 88(3):208-13. PubMed ID: 16210843
[TBL] [Abstract][Full Text] [Related]
4. Current options in the management of apnea of prematurity.
Bhatia J
Clin Pediatr (Phila); 2000 Jun; 39(6):327-36. PubMed ID: 10879934
[TBL] [Abstract][Full Text] [Related]
5. Long-term effects of caffeine therapy for apnea of prematurity.
Schmidt B; Roberts RS; Davis P; Doyle LW; Barrington KJ; Ohlsson A; Solimano A; Tin W;
N Engl J Med; 2007 Nov; 357(19):1893-902. PubMed ID: 17989382
[TBL] [Abstract][Full Text] [Related]
6. Caffeine versus theophylline for apnea of prematurity: a randomised controlled trial.
Skouroliakou M; Bacopoulou F; Markantonis SL
J Paediatr Child Health; 2009 Oct; 45(10):587-92. PubMed ID: 19751376
[TBL] [Abstract][Full Text] [Related]
7. Acute hemodynamic effects of methylxanthine therapy in preterm neonates: Effect of variations in subgroups.
M S; Nayak K; Lewis LES; Kamath A; Purkayastha J
J Trop Pediatr; 2019 Jun; 65(3):264-272. PubMed ID: 30085175
[TBL] [Abstract][Full Text] [Related]
8. Evidence-based methylxanthine use in the NICU.
Spitzer AR
Clin Perinatol; 2012 Mar; 39(1):137-48. PubMed ID: 22341542
[TBL] [Abstract][Full Text] [Related]
9. Caffeine: an evidence-based success story in VLBW pharmacotherapy.
Dobson NR; Hunt CE
Pediatr Res; 2018 Sep; 84(3):333-340. PubMed ID: 29983414
[TBL] [Abstract][Full Text] [Related]
10. Early childhood developmental follow-up of infants with GMH/IVH: effect of methylxanthine therapy.
Ment LR; Scott DT; Ehrenkranz RA; Duncan CC
Am J Perinatol; 1985 Jul; 2(3):223-7. PubMed ID: 4015773
[TBL] [Abstract][Full Text] [Related]
11. National and international guidelines for neonatal caffeine use: Are they evidenced-based?
Eichenwald EC
Semin Fetal Neonatal Med; 2020 Dec; 25(6):101177. PubMed ID: 33214064
[TBL] [Abstract][Full Text] [Related]
12. Caffeine for Apnea of Prematurity trial: benefits may vary in subgroups.
Davis PG; Schmidt B; Roberts RS; Doyle LW; Asztalos E; Haslam R; Sinha S; Tin W;
J Pediatr; 2010 Mar; 156(3):382-7. PubMed ID: 19926098
[TBL] [Abstract][Full Text] [Related]
13. The potential of methylxanthine-based therapies in pediatric respiratory tract diseases.
Oñatibia-Astibia A; Martínez-Pinilla E; Franco R
Respir Med; 2016 Mar; 112():1-9. PubMed ID: 26880379
[TBL] [Abstract][Full Text] [Related]
14. The xanthine treatment of apnea of prematurity.
Lucey JF
Pediatrics; 1975 May; 55(5):584-6. PubMed ID: 1128983
[No Abstract] [Full Text] [Related]
15. Caffeine Therapy in Preterm Infants: The Dose (and Timing) Make the Medicine.
Rostas SE; McPherson C
Neonatal Netw; 2019 Nov; 38(6):365-374. PubMed ID: 31712401
[TBL] [Abstract][Full Text] [Related]
16. Academic Performance, Motor Function, and Behavior 11 Years After Neonatal Caffeine Citrate Therapy for Apnea of Prematurity: An 11-Year Follow-up of the CAP Randomized Clinical Trial.
Schmidt B; Roberts RS; Anderson PJ; Asztalos EV; Costantini L; Davis PG; Dewey D; D'Ilario J; Doyle LW; Grunau RE; Moddemann D; Nelson H; Ohlsson A; Solimano A; Tin W;
JAMA Pediatr; 2017 Jun; 171(6):564-572. PubMed ID: 28437520
[TBL] [Abstract][Full Text] [Related]
17. Management of apnea in infants.
Kriter KE; Blanchard J
Clin Pharm; 1989 Aug; 8(8):577-87. PubMed ID: 2670399
[TBL] [Abstract][Full Text] [Related]
18. Caffeine therapy for apnea of prematurity.
Schmidt B; Roberts RS; Davis P; Doyle LW; Barrington KJ; Ohlsson A; Solimano A; Tin W;
N Engl J Med; 2006 May; 354(20):2112-21. PubMed ID: 16707748
[TBL] [Abstract][Full Text] [Related]
19. High versus low-dose caffeine for apnea of prematurity: a randomized controlled trial.
Mohammed S; Nour I; Shabaan AE; Shouman B; Abdel-Hady H; Nasef N
Eur J Pediatr; 2015 Jul; 174(7):949-56. PubMed ID: 25644724
[TBL] [Abstract][Full Text] [Related]
20. Economic evaluation of caffeine for apnea of prematurity.
Dukhovny D; Lorch SA; Schmidt B; Doyle LW; Kok JH; Roberts RS; Kamholz KL; Wang N; Mao W; Zupancic JA;
Pediatrics; 2011 Jan; 127(1):e146-55. PubMed ID: 21173002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
